Testing a foot monitoring device for adults with diabetes
Part of Hormones & metabolism clinical trials.
This study is testing a device called Feetsee that helps monitor foot health in people with diabetes. It might help catch foot problems early, so you can avoid serious issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 1 or type 2 diabetes.
- You can feel a pulse in at least one foot (meaning blood flow is okay).
- You are comfortable using a smartphone or tablet.
- You have never used the Feetsee system before.
- You do not have an active foot ulcer, severe foot problems, or certain other health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for people with diabetes who have an open foot or ankle ulcer. Researchers want to collect samples to find biomarkers, which are natural signs in the body that could help improve treatment and healing. It may be a good fit if you have a diabetic foot ulcer and are not currently in another drug trial for ulcers.
This trial tests a mobile app to help prevent foot ulcers in people with diabetes who are at high risk. You will use the app to track your foot health and get advice to keep your feet safe.
This trial tests special insoles that send a real-time alert to help you manage foot pressure, combined with foot self-care education. It may help prevent foot problems and improve your daily foot care routine.
This study collects thermal (heat) images of the feet of people with diabetes who have had a healed foot ulcer. The goal is to see if these images can help prevent future foot problems.
This trial tests whether a structured foot-care and exercise program in primary care helps adults with diabetes. It may help you stay more active and reduce foot problems by teaching daily care and safe movement.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.